e-Drug3D

143

TESTOSTERONE


INN
TESTOSTERONE

(is an active metabolite)

cas 58-22-0
CLASS

GENITO
ANDROGENS
TREATMENT OF HYPOGONADISM

ROUTE (list)

TRANSDERMAL BUCCAL IMPLANTATION INJECTION NASAL

NATURAL MOLECULE (link)

ATC code

G03BA03
G03EA02

PK parameters

Tmax 8 HOUR
VD 65 LITER (65 KILOGRAM)
Cl 62.4 LITER / HOUR (65 KILOGRAM)
PPB 98 PERCENT
t1/2 192 HOUR

Target

TARGET ANDROGEN RECEPTOR

PDB
1AFS (RECOMBINANT RAT LIVER 3-ALPHA-HYDROXYSTEROID DEHYDROGENASE (3-ALPHA-HSD) COMPLEXED WITH NADP AND TESTOSTERONE)

Ligand code = TES (link to the list of PDB complexes)

Download experimental 3D coordinates of TES with added hydrogens

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one

Formula:
C19H28O2

Calculated chemical properties:

MW 288.41
NB_atoms 21
XLogP 3.88
PSA 37.847
NB_HD 1
NB_HA 2
fsp3 0.84
Lipinski(0=no;1=yes) 1

FDA
NDA 080911 (pdf not found) INN (TESTOSTERONE) TESTOPEL (ENDO OPERATIONS) APPROVAL= AP YEAR= 1972
NDA 086417 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (DR REDDYS) APPROVAL= AP YEAR= 1983 DISCONTINUED
NDA 086419 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (WATSON LABS) APPROVAL= AP YEAR= 1983 DISCONTINUED
NDA 086420 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (WATSON LABS) APPROVAL= AP YEAR= 1983 DISCONTINUED
NDA 019762 (pdf not found) INN (TESTOSTERONE) TESTODERM (ALZA) APPROVAL= AP YEAR= 1993 DISCONTINUED
NDA 020489 (label) INN (TESTOSTERONE) ANDRODERM (ABBVIE) APPROVAL= AP YEAR= 1995 DISCONTINUED
NDA 020791 (pdf not found) INN (TESTOSTERONE) TESTODERM TTS (ALZA) APPROVAL= AP YEAR= 1997 DISCONTINUED
NDA 021015 (label) INN (TESTOSTERONE) ANDROGEL (BESINS HLTHCARE) APPROVAL= AP YEAR= 2000
NDA 021454 (label) INN (TESTOSTERONE) TESTIM (ENDO OPERATIONS) APPROVAL= AP YEAR= 2002
NDA 021543 (label) INN (TESTOSTERONE) STRIANT (AUXILIUM PHARMS LLC) APPROVAL= AP YEAR= 2003 DISCONTINUED
NDA 076737 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ACTAVIS LABS UT INC) APPROVAL= AP YEAR= 2006
NDA 076744 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (STRIDES PHARMA INTL) APPROVAL= AP YEAR= 2007
NDA 022504 (label) INN (TESTOSTERONE) AXIRON (ELI LILLY AND CO) APPROVAL= AP YEAR= 2010 DISCONTINUED
NDA 021463 (label) INN (TESTOSTERONE) FORTESTA (ENDO OPERATIONS) APPROVAL= AP YEAR= 2010 DISCONTINUED
NDA 022309 (label) INN (TESTOSTERONE) ANDROGEL (BESINS HLTHCARE) APPROVAL= AP YEAR= 2011
NDA 202763 (label) INN (TESTOSTERONE) TESTOSTERONE (ANI PHARMS) APPROVAL= AP YEAR= 2012 DISCONTINUED
NDA 203098 (label) INN (TESTOSTERONE) TESTOSTERONE (PERRIGO ISRAEL) APPROVAL= AP YEAR= 2013 DISCONTINUED
NDA 204399 (label) INN (TESTOSTERONE) VOGELXO (UPSHER SMITH LABS) APPROVAL= AP YEAR= 2014
NDA 205488 (label) INN (TESTOSTERONE) NATESTO (ACERUS) APPROVAL= AP YEAR= 2014
NDA 204571 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ACTAVIS LABS UT INC) APPROVAL= AP YEAR= 2015
NDA 204268 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2015
NDA 205328 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ACTAVIS LABS UT INC) APPROVAL= AP YEAR= 2017
NDA 204255 (label) INN (TESTOSTERONE) TESTOSTERONE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2017
NDA 205781 (label) INN (TESTOSTERONE) TESTOSTERONE (PADAGIS ISRAEL) APPROVAL= AP YEAR= 2017
NDA 207337 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (SANDOZ INC) APPROVAL= TA YEAR= 2017
NDA 091073 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ACTAVIS LABS UT INC) APPROVAL= AP YEAR= 2017
NDA 208061 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (LUPIN) APPROVAL= AP YEAR= 2017
NDA 209533 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (CIPLA) APPROVAL= AP YEAR= 2018
NDA 208560 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (LUPIN) APPROVAL= AP YEAR= 2019
NDA 204570 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ACTAVIS LABS UT INC) APPROVAL= AP YEAR= 2019
NDA 207373 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (AMNEAL) APPROVAL= AP YEAR= 2019
NDA 208620 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ENCUBE) APPROVAL= AP YEAR= 2019
NDA 209390 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (TWI PHARMS) APPROVAL= AP YEAR= 2019 DISCONTINUED
NDA 210835 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (XIROMED) APPROVAL= AP YEAR= 2020
NDA 209181 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (APOTEX) APPROVAL= AP YEAR= 2020 DISCONTINUED
NDA 212301 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ENCUBE) APPROVAL= AP YEAR= 2021
NDA 212882 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ALEMBIC) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 213922 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ALEMBIC) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 209836 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (TWI PHARMS) APPROVAL= AP YEAR= 2021 DISCONTINUED
NDA 212984 (pdf not found) INN (TESTOSTERONE) TESTOSTERONE (ENCUBE) APPROVAL= AP YEAR= 2021

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

144

TESTOSTERONE PROPIONATE

DISCONTINUED


INN
TESTOSTERONE PROPIONATE

(has an active metabolite)

cas 57-85-2
CLASS

GENITO
ANDROGENIC
RAPIDLY HYDROLYZED IN TESTOSTERONE

ROUTE (list)

INJECTION

ATC code

G03BA03
G03EA02

PK parameters

Target

TARGET ANDROGEN RECEPTOR

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file [(8R,9S,10R,13S,14S,17S)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] propanoate

Formula:
C22H32O3

Calculated chemical properties:

MW 344.48
NB_atoms 25
XLogP 4.84
PSA 41.144
NB_HD 0
NB_HA 3
fsp3 0.82
Lipinski(0=no;1=yes) 1

FDA
NDA 080254 (pdf not found) INN (TESTOSTERONE PROPIONATE) TESTOSTERONE PROPIONATE (LILLY) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 080276 (pdf not found) INN (TESTOSTERONE PROPIONATE) TESTOSTERONE PROPIONATE (ELKINS SINN) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 083595 (pdf not found) INN (TESTOSTERONE PROPIONATE) TESTOSTERONE PROPIONATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 085490 (pdf not found) INN (TESTOSTERONE PROPIONATE) TESTOSTERONE PROPIONATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089283 (pdf not found) INN (TESTOSTERONE PROPIONATE) TESTOSTERONE PROPIONATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 080741 (pdf not found) INN (TESTOSTERONE PROPIONATE) TESTOSTERONE PROPIONATE (BEL MAR) APPROVAL= AP YEAR= 1973 DISCONTINUED
NDA 080742 (pdf not found) INN (TESTOSTERONE PROPIONATE) TESTOSTERONE PROPIONATE (BEL MAR) APPROVAL= AP YEAR= 1973 DISCONTINUED
NDA 080743 (pdf not found) INN (TESTOSTERONE PROPIONATE) TESTOSTERONE PROPIONATE (BEL MAR) APPROVAL= AP YEAR= 1973 DISCONTINUED
NDA 080188 (pdf not found) INN (TESTOSTERONE PROPIONATE) TESTOSTERONE PROPIONATE (WATSON LABS) APPROVAL= AP YEAR= 1974 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1334

TESTOSTERONE ENANTHATE


INN
TESTOSTERONE ENANTHATE

(has an active metabolite)

cas 315-37-7
CLASS

HORMONES
ANDROGENIC
HYDROLYSED BY ESTERASES

ROUTE (list)

INJECTION SUBCUTANEOUS

ATC code

G03BA03
G03EA02

PK parameters

Solubility

INSOLUBLE IN WATER


Target

TARGET ANDROGEN RECEPTOR

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file Androst-4-en-3-one, 17-[(1-oxoheptyl)oxy]-, (17.beta.)-

Formula:
C26H40O3

Calculated chemical properties:

MW 400.58
NB_atoms 29
XLogP 6.40
PSA 41.545
NB_HD 0
NB_HA 3
fsp3 0.85
Lipinski(0=no;1=yes) 0

FDA
NDA 083667 (pdf not found) INN (TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 085599 (pdf not found) INN (TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 085860 (pdf not found) INN (ESTRADIOL VALERATE ; TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089324 (pdf not found) INN (TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089325 (pdf not found) INN (TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 009165 (label) INN (TESTOSTERONE ENANTHATE) DELATESTRYL (ENDO PHARMS) APPROVAL= AP YEAR= 1953 DISCONTINUED
NDA 085598 (pdf not found) INN (TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE (WATSON PHARMS INC) APPROVAL= AP YEAR= 1980 DISCONTINUED
NDA 085865 (pdf not found) INN (ESTRADIOL VALERATE ; TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE AND ESTRADIOL VALERATE (WATSON LABS) APPROVAL= AP YEAR= 1981 DISCONTINUED
NDA 086423 (pdf not found) INN (ESTRADIOL VALERATE ; TESTOSTERONE ENANTHATE) DITATE-DS (SAVAGE LABS) APPROVAL= AP YEAR= 1982 DISCONTINUED
NDA 040575 (pdf not found) INN (TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE (NEXUS) APPROVAL= AP YEAR= 2006
NDA 040647 (pdf not found) INN (TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE (RISING) APPROVAL= AP YEAR= 2009 DISCONTINUED
NDA 091120 (pdf not found) INN (TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE (HIKMA FARMACEUTICA) APPROVAL= AP YEAR= 2012
NDA 209863 (label) INN (TESTOSTERONE ENANTHATE) XYOSTED AUTOINJECTOR (ANTARES PHARMA INC) APPROVAL= AP YEAR= 2018
NDA 212659 (pdf not found) INN (TESTOSTERONE ENANTHATE) TESTOSTERONE ENANTHATE (EUGIA PHARMA) APPROVAL= AP YEAR= 2024

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1335

TESTOSTERONE CYPIONATE


INN
TESTOSTERONE CYPIONATE

(has an active metabolite)

cas 58-20-8
CLASS

HORMONES
ANDROGENIC
HYDROLYSED BY ESTERASES

ROUTE (list)

INJECTION INTRAMUSCULAR

ATC code

G03BA03
G03EA02

PK parameters

Solubility

INSOLUBLE IN WATER


Target

TARGET ANDROGEN RECEPTOR

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file Androst-4-en-3-one, 17-(3-cyclopentyl-1-oxopropoxy)-, (17.beta.)-

Formula:
C27H40O3

Calculated chemical properties:

MW 412.59
NB_atoms 30
XLogP 6.40
PSA 41.545
NB_HD 0
NB_HA 3
fsp3 0.85
Lipinski(0=no;1=yes) 0

FDA
NDA 084401 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (WATSON LABS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089326 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 089327 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (QUAD PHARMS) APPROVAL= - YEAR= 0 DISCONTINUED
NDA 086029 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (WATSON LABS) APPROVAL= AP YEAR= 1978 DISCONTINUED
NDA 085635 (label) INN (TESTOSTERONE CYPIONATE) DEPO-TESTOSTERONE (PFIZER) APPROVAL= AP YEAR= 1979
NDA 017968 (pdf not found) INN (ESTRADIOL CYPIONATE ; TESTOSTERONE CYPIONATE) DEPO-TESTADIOL (PHARMACIA AND UPJOHN) APPROVAL= AP YEAR= 1980 DISCONTINUED
NDA 086030 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (WATSON PHARMS INC) APPROVAL= AP YEAR= 1981 DISCONTINUED
NDA 085603 (pdf not found) INN (ESTRADIOL CYPIONATE ; TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE (WATSON LABS) APPROVAL= AP YEAR= 1986 DISCONTINUED
NDA 040530 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (PADAGIS US) APPROVAL= AP YEAR= 2005
NDA 040615 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (CAPLIN ONE LABS) APPROVAL= AP YEAR= 2006 DISCONTINUED
NDA 040652 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (RISING) APPROVAL= AP YEAR= 2006 DISCONTINUED
NDA 090387 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (HIKMA) APPROVAL= AP YEAR= 2010
NDA 091244 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (HIKMA FARMACEUTICA) APPROVAL= AP YEAR= 2012
NDA 201720 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (SUN PHARM INDS LTD) APPROVAL= AP YEAR= 2013 DISCONTINUED
NDA 207742 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (AM REGENT) APPROVAL= AP YEAR= 2017
NDA 210362 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (CIPLA) APPROVAL= AP YEAR= 2018
NDA 206368 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (WILSHIRE PHARMS INC) APPROVAL= AP YEAR= 2019
NDA 216318 (label) INN (TESTOSTERONE CYPIONATE) AZMIRO (AZURITY) APPROVAL= AP YEAR= 2022
NDA 215351 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (XIROMED) APPROVAL= AP YEAR= 2023
NDA 211817 (pdf not found) INN (TESTOSTERONE CYPIONATE) TESTOSTERONE CYPIONATE (EUGIA PHARMA) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1718

TESTOSTERONE UNDECANOATE


INN
TESTOSTERONE UNDECANOATE

(has an active metabolite)

cas 5949-44-0
CLASS

GENITO
ANDROGEN INDICATED FOR TESTOSTERONE REPLACEMENT THERAPY IN ADULT MALES
CLIVAGE BY TISSUE ESTERASES
RAPIDLY HYDROLYZED IN TESTOSTERONE

ROUTE (list)

INTRAMUSCULAR ORAL

ATC code

G03BA03
G03EA02

PK parameters

Solubility

INSOLUBLE IN WATER


Target

TARGET ANDROGEN RECEPTOR

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file Androst-4-en-3-one, 17-[(1-oxoundecyl)oxy]-, (17beta)-

Formula:
C30H48O3

Calculated chemical properties:

MW 456.68
NB_atoms 33
XLogP 7.96
PSA 41.224
NB_HD 0
NB_HA 3
fsp3 0.87
Lipinski(0=no;1=yes) 0

FDA
NDA 022219 (label) INN (TESTOSTERONE UNDECANOATE) AVEED (ENDO OPERATIONS) APPROVAL= AP YEAR= 2014
NDA 207583 (pdf not found) INN (TESTOSTERONE UNDECANOATE) TESTOSTERONE UNDECANOATE (HIKMA PHARMACEUTICALS USA INC) APPROVAL= TA YEAR= 2016
NDA 206089 (label) INN (TESTOSTERONE UNDECANOATE) JATENZO (TOLMAR) APPROVAL= AP YEAR= 2019
NDA 208088 (label) INN (TESTOSTERONE UNDECANOATE) TLANDO (VERITY) APPROVAL= AP YEAR= 2022
NDA 213953 (label) INN (TESTOSTERONE UNDECANOATE) KYZATREX (MARIUS) APPROVAL= AP YEAR= 2022

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

1825

PRASTERONE


INN
PRASTERONE

(has an active metabolite)

cas 53-43-0
CLASS

HORMONES
TREATMENT OF MODERATE TO SEVERE DYSPAREUNIA, A SYMPTOM OF VULVAR AND VAGINAL ATROPHY, DUE TO MENOPAUSE
STEROID
IS CONVERTED INTO ACTIVE ANDROGENS AND/OR ESTROGENS

ROUTE (list)

VAGINAL

ATC code

A14AA07
G03XX01
G03EA03

PK parameters

Solubility

INSOLUBLE IN WATER


Target

TARGET HYDROXYSTEROID DEHYDROGENASES
5ALPHA-REDUCTASES
AROMATASES

PDB
1Q22 (CRYSTAL STRUCTURE OF HUMAN CHOLESTEROL SULFOTRANSFERASE (SULT2B1B) IN THE PRESENCE OF DHEA AND PAP)

Ligand code = AND (link to the list of PDB complexes)

Download experimental 3D coordinates of AND with added hydrogens

DrugCentral

Unknown

Download SDF file Androst-5-en-17-one, 3-hydroxy-, (3beta)-

Formula:
C19H28O2

Calculated chemical properties:

MW 288.41
NB_atoms 21
XLogP 3.88
PSA 39.203
NB_HD 1
NB_HA 2
fsp3 0.84
Lipinski(0=no;1=yes) 1

FDA
NDA 208470 (label) INN (PRASTERONE) INTRAROSA (MILLICENT) APPROVAL= AP YEAR= 2016

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL